v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 3 Months Ended 80 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (1,257,051) $ (910,161) $ (47,630,285)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation (17,923) 96,662 2,581,315
Stock issued in connection with license agreements 0 0 6,613,718
Stock issued in connection with consulting agreement 0 0 158,262
Amortization of deferred financing costs 81,396 0 2,205,909
Amortization of debt discount 328,761 0 5,587,274
Non-cash charge for beneficial conversion feature 0 0 1,137,762
Non-cash interest expense 0 0 3,007,018
Expenses paid on behalf of the Company satisfied through the issuance of notes 0 0 51,253
Depreciation 543 1,755 57,585
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (14,074) 388,749 (55,972)
Security deposits 0 0 (13,342)
Accounts payable 262,926 416,105 1,255,676
Accrued expenses and accrued interest (1,097) (122,679) 322,061
Deferred rent (1,232) (572) 10,953
Net cash used in operating activities (617,751) (130,141) (24,710,813)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchase of equipment 0 0 (61,709)
Net cash used in investing activities 0 0 (61,709)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from notes payable to related parties 0 0 3,063,484
Proceeds from senior convertible notes 0 0 13,963,838
Proceeds from Galenica, Ltd. promissory note 0 0 1,000,000
Payments for deferred financing costs (25,000) 0 (1,542,603)
Repayment of amounts loaned under related party notes 0 0 (1,981,574)
Proceeds from sale of equity securities 533,000 0 10,990,270
Repurchase of outstanding warrants (33,000) 0 (33,000)
Proceeds from receipt of stock subscriptions and issuances of common stock 0 0 4,827
Net cash provided by financing activities 475,000 0 25,465,242
NET INCREASE (DECREASE) IN CASH (142,751) (130,141) 692,720
CASH - BEGINNING OF PERIOD 835,471 1,985,334 0
CASH - END OF PERIOD 692,720 1,855,193 692,720
Cash paid for interest 26,938 0 45,363
Supplemental Disclosure of Non-Cash Financing Activities:      
Conversion of notes payable and accrued interest to common stock 0 0 18,897,167
Reclassification of deferred financing fees to additional paid-in capital 0 0 148,014
Stock issued to technology finders and licensors 0 0 155
Warrants issued to placement agent 0 0 854,608
Debt discount on senior convertible notes 0 0 6,312,768
Deemed dividend - beneficial conversion feature 180,502 0 180,502
Accrued deferred financing cost 0 0 30,803
Accrued private placement expenses $ 25,867 $ 0 $ 25,867